In the Research Letter titled “Trends in Pricing and Out-of-Pocket Spending on Entecavir Among Commercially Insured Patients, 2014-2018”,1 published January 21, 2022, an older version of the Figure was inadvertently published. The Figure included data points for out-of-pocket spending that incorrectly included a denominator of patients taking both brand name and generic entecavir, rather than generic only. This article has been corrected.1
References
- 1.Alpern JD, Joo H, Link B, et al. Trends in pricing and out-of-pocket spending on entecavir among commercially insured patients, 2014-2018. JAMA Netw Open. 2022;5(1):e2144521. doi: 10.1001/jamanetworkopen.2021.44521 [DOI] [PMC free article] [PubMed] [Google Scholar]